KP Tissue Statistics
Total Valuation
KP Tissue has a market cap or net worth of CAD 91.61 million.
Market Cap | 91.61M |
Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | Jun 30, 2025 |
Share Statistics
KP Tissue has 10.00 million shares outstanding. The number of shares has increased by 0.23% in one year.
Current Share Class | 10.00M |
Shares Outstanding | 10.00M |
Shares Change (YoY) | +0.23% |
Shares Change (QoQ) | +0.07% |
Owned by Insiders (%) | 0.52% |
Owned by Institutions (%) | 9.02% |
Float | 9.95M |
Valuation Ratios
The trailing PE ratio is 29.99 and the forward PE ratio is 16.95.
PE Ratio | 29.99 |
Forward PE | 16.95 |
PS Ratio | n/a |
PB Ratio | 1.33 |
P/TBV Ratio | 1.33 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00
Current Ratio | 1.00 |
Quick Ratio | 1.00 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 4.37%.
Return on Equity (ROE) | 4.37% |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | 1,129 |
Employee Count | 2,700 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, KP Tissue has paid 56,000 in taxes.
Income Tax | 56,000 |
Effective Tax Rate | 1.80% |
Stock Price Statistics
The stock price has increased by +8.53% in the last 52 weeks. The beta is 0.30, so KP Tissue's price volatility has been lower than the market average.
Beta (5Y) | 0.30 |
52-Week Price Change | +8.53% |
50-Day Moving Average | 8.58 |
200-Day Moving Average | 8.26 |
Relative Strength Index (RSI) | 66.55 |
Average Volume (20 Days) | 13,046 |
Short Selling Information
The latest short interest is 273,691, so 2.74% of the outstanding shares have been sold short.
Short Interest | 273,691 |
Short Previous Month | 279,887 |
Short % of Shares Out | 2.74% |
Short % of Float | 2.75% |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | 3.11M |
Net Income | 3.05M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | 0.31 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | 68.95M |
Book Value Per Share | 6.90 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.72, which amounts to a dividend yield of 7.86%.
Dividend Per Share | 0.72 |
Dividend Yield | 7.86% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 235.74% |
Buyback Yield | -0.23% |
Shareholder Yield | 7.63% |
Earnings Yield | 3.33% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |